Literature DB >> 1510931

Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors.

J Veldscholte1, C A Berrevoets, N D Zegers, T H van der Kwast, J A Grootegoed, E Mulder.   

Abstract

The hormone-induced transformation process of the androgen receptor in the androgen-responsive human prostatic carcinoma cell line LNCaP was studied. Immunoprecipitation of the nontransformed cytosolic receptor (8S on sucrose gradients) with a specific monoclonal antibody (F39.4.1) resulted in coprecipitation of three heat-shock proteins (hsp90, hsp70, and hsp56). Upon incubation of the cells with the synthetic androgen R1881, the sedimentation value of the receptor complex decreased to an intermediate form of 6S, and an almost complete loss of coprecipitating heat-shock proteins was observed. After a 2-h incubation, the receptor was recovered in considerable part from the nuclear fraction (extraction with high salt; 4.6S form). By use of the bifunctional cross-linker dimethyl pimelimidate, dissociation of the 8S complex, but not of the 6S complex, was blocked. A newly developed monoclonal antibody (F52.24.4), directed against the C-terminal part of the DNA-binding domain of the androgen receptor, specifically recognized both the 4.6S and the 6S forms of the receptor but did not react with the nontransformed 8S form. It is concluded that the unoccupied androgen receptor is associated with several heat-shock proteins and that transformation of the receptor to the tight nuclear-binding form is a multistep process that involves the dissociation of heat-shock proteins from the receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510931     DOI: 10.1021/bi00147a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

Review 1.  Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors:  Christopher Foley; Nicholas Mitsiades
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

Review 2.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

3.  The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.

Authors:  Anthony J Saporita; Junkui Ai; Zhou Wang
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

4.  FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform.

Authors:  Zuocheng Yang; Irene M Wolf; Hanying Chen; Sumudra Periyasamy; Zhuang Chen; Weidong Yong; Shu Shi; Weihong Zhao; Jianming Xu; Arun Srivastava; Edwin R Sánchez; Weinian Shou
Journal:  Mol Endocrinol       Date:  2006-07-27

5.  Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.

Authors:  Weidong Yong; Zuocheng Yang; Sumudra Periyasamy; Hanying Chen; Selcul Yucel; Wei Li; Leanne Y Lin; Irene M Wolf; Martin J Cohn; Laurence S Baskin; Edwin R Sa Nchez; Weinian Shou
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

6.  Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Seong-Jin Kim; David Danielpour
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 7.  Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

Authors:  Izabela Sokolowska; Alisa G Woods; Mary Ann Gawinowicz; Urmi Roy; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2012-10-18       Impact factor: 9.261

8.  Human androgen receptor expressed in HeLa cells activates transcription in vitro.

Authors:  P De Vos; J Schmitt; G Verhoeven; H G Stunnenberg
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

Review 9.  Androgen signal transduction and prostatic carcinoma.

Authors:  H Klocker; Z Culig; F Kaspar; A Hobisch; J Eberle; A Reissigl; G Bartsch
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  Diastereomers of the brominated flame retardant 1,2-dibromo-4-(1,2 dibromoethyl)cyclohexane induce androgen receptor activation in the hepg2 hepatocellular carcinoma cell line and the lncap prostate cancer cell line.

Authors:  Hazem Khalaf; Anders Larsson; Håkan Berg; Robert McCrindle; Gilles Arsenault; Per-Erik Olsson
Journal:  Environ Health Perspect       Date:  2009-08-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.